The Authors' Reply

David R. Head(University of Southern California), David R. Kjeldsberg, Lizardo Cerezo(Orlando Regional Medical Center), James Avakian(University of Utah)

American Journal of Clinical Pathology

February 1, 1990

10.1093/ajcp/93.2.298a

Cited by 0

Related Papers

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

|Blood|2000|1.6k

Age and acute myeloid leukemia

|Blood|2006|1.4k

Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

|Blood|1997|869

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

|Journal of Clinical Oncology|1990|786

Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia

|New England Journal of Medicine|1991|722